Basic and diluted net loss per share of common stock were calculated as follows:


	Year Ended December 31,
	2024			2023
Numerator:
Net loss	$	(84,969	)	$	(43,555	)
Denominator:
Weighted-average shares of common stock outstanding including shares issuable under equity-classified pre-funded warrants		33,313,849			5,153,711
Less: weighted-average unvested restricted shares of common stock		—			(288	)
Weighted-average shares used to compute net loss per share of common stock, basic and diluted		33,313,849			5,153,423
Net loss per share attributable to common stockholders, basic and diluted	$	(2.55	)	$	(8.45	)

Pre-funded warrants totaling 4,666,332 shares have been included in the computation of basic and diluted net loss per share of common stock for the year ended December 31, 2024 as the pre-funded warrants are issuable for nominal consideration pursuant to their terms.

The Company’s potential dilutive securities, which include stock options and warrants for the purchase of common stock, have been excluded from the computation of diluted net loss per share as the effect would be antidilutive. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share is the same. The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share due to their anti-dilutive effect:


	Year Ended December 31,
	2024		2023
Stock options outstanding		4,499,702		1,749,475
Warrants for the purchase of common stock		4,677		214,997
Total		4,504,379		1,964,472